References
- K. Le, D. Tran, A. Nguyen, and L. Le, A screening of neuraminidase inhibition activities of isoquinolone alkaloids in Coptis chinensis using molecular docking and pharmacophore analysis, ACS Omega 5 (2020), pp. 30315–30322. doi:10.1021/acsomega.0c04847.
- P. Inamdar, S. Bhandari, B. Sonawane, A. Hole, and C. Jadhav, Structure optimization of neuraminidase inhibitors as potential antiInfluenza (H1N1Inhibitors) agents using QSAR and molecular docking studies, Iran. J. Pharm. Res. 13 (2014), pp. 49–65.
- S.V. Jagtap and A.A. Khan, Synthesis and biological activities of aurones: A review, Int. J. Pure App. Biosci. 4 (2016), pp. 137–155. doi:10.18782/2320-7051.2230.
- G. Sui, T. Li, B. Zhang, R. Wang, H. Hao, and W. Zhou, Recent advances on synthesis and biological activities of aurones, Bioorg. Med. Chem. 29 (2021), pp. 115895. doi:10.1016/j.bmc.2020.115895.
- R. Haudecoeur and A. Boumendjel, Recent advances in the medicinal chemistry of aurones, Curr. Med. Chem. 19 (2012), pp. 2861–2875. doi:10.2174/092986712800672085.
- N. Kaur, R.K. Dhawan, and B. Singh, Green chemistry in organic synthesis, Int. J. Life Sci. Res. 7 (2020), pp. 26–36.
- N.R. Rao, S. Jena, M. Mukherjee, B. Maiti, and K. Chanda, Green synthesis of biologically active heterocycles of medicinal importance: A review, Environ. Chem. Lett. 19 (2021), pp. 3315–3358. doi:10.1007/s10311-021-01232-9.
- A. Al-Mulla, A review: Biological importance of heterocyclic compounds, Der Pharma. Chemica 9 (2017), pp. 141–147.
- P.H. Narnaware and P.N. Shende, An overview on heterocyclic compounds and their versatile applications, IJCESR 5 (2018), pp. 159–162.
- M. Muehlebach, M. Boeger, F. Cederbaum, D. Cornes, A. Friedmann, J. Glock, T. Niderman, A. Stoller, and T. Wagner, Aryldiones incorporating a [1,4,5]oxadiazepane ring, Part I: Discovery of the novel cereal herbicide pinoxaden, Bioorg. Med. Chem. 17 (2009), pp. 4241–4256. doi:10.1016/j.bmc.2008.12.062.
- S.L. Gaonkar and U.N. Vignesh, Synthesis and pharmacological properties of chalcones: A review, Res. Chem. Intermed. 43 (2017), pp. 6043–6077. doi:10.1007/s11164-017-2977-5.
- S. Verma, A.K. Srivastava, and O. Pandey, A review on chalcones synthesis and their biological activity, Pharma. Tutor. 6 (2018), pp. 22–39. doi:10.29161/PT.v6.i2.2018.22.
- K.L. Ameta, N.S. Rathore, B. Kumar, E.S. Malaga, P.V. Manuela, R.H. Gilman, and B.L. Verma, Synthesis and trypanocidal evaluation of some novel 2-(substituted benzylidene)-5, 7-dibromo-6-hydroxy-1-benzofuran-3(2H)-ones, Int. J. Org. Chem. 02 (2012), pp. 295–301. doi:10.4236/ijoc.2012.223040.
- https://www.rcsb.org/structure/3TI6. (Accessed 11 May 2022.)
- R. Thomsen and M.H. Christense, MolDock: A new technique for high-accuracy molecular docking, J. Med. Chem. 49 (2006), pp. 3315–3321. doi:10.1021/jm051197e.
- S. Venkateswarlu, G.K. Panchagnula, A.L. Gottumukkala, and G.V. Subbaraju, Synthesis, structural revision, and biological activities of 4′-chloroaurone, a metabolite of marine brown alga Spatoglossum variabile, Tetrahedron 63 (2007), pp. 6909–6914. doi:10.1016/j.tet.2007.04.048.
- L.V. Gubareva, L. Kaiser, and F.G. Hayden, Influenza virus neuraminidase inhibitors, Lancet 355 (2000), pp. 827–835. doi:10.1016/S0140-6736(99)11433-8.
- J.L. McAuley, B.P. Gilbertson, S. Trifkovic, L.E. Brown, and J.L. McKimm-Breschkin, Influenza virus neuraminidase structure and functions, Front. Microbiol. 10 (2019), pp. 1–13. doi:10.3389/fmicb.2019.00039.